The U.S. FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent Influenza disease.

The FDA has approved a new flu vaccine nasal spray for at-home use. While this self-administered version won't be available for this year's flu season, interest in nasal spray products is growing.

Scientists have hailed a new spray that has the potential to save lives by protecting us from COVID-19 as well as the flu and colds, in a breakthrough discovery. A study has shown that a new nasal spray could neutralise germs in the nose, preventing infection.

A no-frills nasal spray could potentially provide effective protection against "deadly respiratory infections" and Covid-19, tests on mice suggest. In findings published in the journal Advanced Materials,

Researchers are exploring a new nasal spray designed to protect against respiratory illnesses like colds, flu, and COVID-19. The spray, developed by Brigham and Women's Hospital, uses a unique formulation called PCANS (Pathogen Capture and Neutralizing Spray).

Nasal Spray Beats Flu, Colds, Covid-19 With 99 Percent Success, Researchers Say. The spray functions by creating a gel-like matrix within the nasal passages. A nurse gives a s

The Food and Drug Administration (FDA) has approved the first-ever influenza vaccine that can be administered at home. It’s a nasal spray vaccine called FluMist, and it’s been

Brigham researchers have developed a nasal spray called PCANS that blocks a wide range of respiratory infections by trapping and neutralizing pathogens in the nose. In lab and animal tests, the spray effectively prevented infection,